CFO4Life Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$415K Buy
3,746
+30
+0.8% +$3.33K 0.06% 136
2025
Q1
$416K Sell
3,716
-549
-13% -$61.5K 0.07% 130
2024
Q4
$394K Buy
4,265
+112
+3% +$10.3K 0.07% 133
2024
Q3
$348K Sell
4,153
-1,749
-30% -$147K 0.06% 141
2024
Q2
$405K Buy
5,902
+83
+1% +$5.69K 0.08% 127
2024
Q1
$426K Sell
5,819
-3,502
-38% -$257K 0.08% 123
2023
Q4
$755K Sell
9,321
-3,925
-30% -$318K 0.14% 83
2023
Q3
$993K Sell
13,246
-1,434
-10% -$107K 0.23% 55
2023
Q2
$1.13M Buy
14,680
+3,489
+31% +$269K 0.24% 51
2023
Q1
$929K Sell
11,191
-79
-0.7% -$6.56K 0.21% 53
2022
Q4
$968K Sell
11,270
-3,229
-22% -$277K 0.21% 64
2022
Q3
$894K Sell
14,499
-288
-2% -$17.8K 0.24% 49
2022
Q2
$901K Buy
14,787
+302
+2% +$18.4K 0.22% 51
2022
Q1
$861K Sell
14,485
-269
-2% -$16K 0.18% 57
2021
Q4
$1.07M Buy
+14,754
New +$1.07M 0.22% 51
2020
Q3
Sell
-3,531
Closed -$272K 131
2020
Q2
$272K Sell
3,531
-1,153
-25% -$88.8K 0.1% 97
2020
Q1
$350K Sell
4,684
-1,528
-25% -$114K 0.19% 74
2019
Q4
$404K Buy
6,212
+138
+2% +$8.98K 0.17% 80
2019
Q3
$385K Buy
6,074
+38
+0.6% +$2.41K 0.17% 80
2019
Q2
$408K Buy
6,036
+952
+19% +$64.4K 0.19% 78
2019
Q1
$331K Sell
5,084
-858
-14% -$55.9K 0.16% 86
2018
Q4
$372K Buy
5,942
+29
+0.5% +$1.82K 0.16% 81
2018
Q3
$457K Sell
5,913
-70
-1% -$5.41K 0.2% 80
2018
Q2
$424K Sell
5,983
-1,600
-21% -$113K 0.18% 84
2018
Q1
$572K Buy
7,583
+26
+0.3% +$1.96K 0.48% 33
2017
Q4
$541K Sell
7,557
-2,538
-25% -$182K 0.43% 40
2017
Q3
$818K Sell
10,095
-334
-3% -$27.1K 0.66% 21
2017
Q2
$738K Buy
10,429
+317
+3% +$22.4K 0.68% 16
2017
Q1
$687K Buy
+10,112
New +$687K 0.62% 24